TER TERRASCEND CORP

TerrAscend Announces Symbol Change on OTC Markets to TSNDF

TerrAscend Announces Symbol Change on OTC Markets to TSNDF

OTC Markets symbol change aligns with recent TSX listing

TORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that its common shares (the “Common Shares”), previously trading on the OTC Market under the ticker symbol “TRSSF”, are to commence trading on the OTC Market under the ticker symbol “TSNDF” effective today, July 6, 2023.

The Common Shares recently began trading under the ticker symbol “TSND” on the Toronto Stock Exchange (the “TSX”). Moving to a new stock ticker symbol on the OTC Markets aligns with the Company’s recent TSX listing. No action is required by shareholders with respect to either ticker symbol change.

About TerrAscend Corp.

TerrAscend is a leading TSX-listed cannabis company with interests across the North American cannabis sector, including vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. and retail operations in Canada. TerrAscend Growth operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend Growth’s cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns or licenses several synergistic businesses and brands including Gage Cannabis, The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana, and Valhalla Confections. For more information visit . 

Caution Regarding Cannabis Operations in the United States

Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the U.S. Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.

While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend’s operations and financial performance.

Notice Regarding Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe”, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits. Examples of forward-looking information contained in this press release include statements regarding the impacts of the listing on the TSX Listing; and expectations for other economic, business, and/or competitive factors.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, current and future market conditions; risks related to federal, state, provincial, territorial, local and foreign government laws, rules and regulations, including federal and state laws in the United States relating to cannabis operations in the United States; and the risk factors set out in the Company’s most recently filed MD&A, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at and in the section titled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission (the “SEC”) on March 16, 2023, the Company’s Annual Report on Form 10-K/A for the year ended December 31, 2022 filed with the SEC on May 4, 2023 and its subsequently filed quarterly reports on Form 10-Q.

The statements in this press release are made as of the date of this press release. TerrAscend disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

For more information regarding TerrAscend:

Keith Stauffer

Chief Financial Officer

717-343-5386

Briana Chester

MATTIO Communications

424-465-4419



EN
06/07/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on TERRASCEND CORP

 PRESS RELEASE

TerrAscend to Host First Quarter 2025 Earnings Conference Call

TerrAscend to Host First Quarter 2025 Earnings Conference Call TORONTO, April 03, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that it will host a scheduled conference call to discuss the results for its first quarter ended March 31, 2025 on Thursday, May 8, 2025 at 5:00 p.m. Eastern Time. The Company will report its financial results for the first quarter 2025 the same day after market close. CONFERENCE CALL DETAILS  Date:Thursday, May 8, 2025Time:5:00 p.m. Eastern TimeWeb...

 PRESS RELEASE

TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results

TerrAscend Reports Fourth Quarter and Full Year 2024 Financial Results Fourth Quarter Net Revenue of $74.4 million, up 0.3% from $74.2 million in the third quarter of 2024 Fourth Quarter Gross Profit Margin of 50.2%, up 140 basis points from 48.8% in the third quarter of 2024 Full Year 2024 Net Cash provided by continuing operations of $38.0 million and Free Cash Flow1 of $28.6 million 10th consecutive quarter of positive Cash Flow from continuing operations and 6th consecutive quarter of positive Free Ca...

 PRESS RELEASE

TerrAscend Announces Preliminary Fourth Quarter 2024 Financial Results...

TerrAscend Announces Preliminary Fourth Quarter 2024 Financial Results and Schedules Earnings Conference Call Net Revenue of $74.4 million, up 0.3% from $74.2 million in the third quarter of 2024 Gross Profit Margin of 50.2%, an increase of 140 basis points quarter-over quarter Generated Positive Cashflow from Operations in the quarter Fourth quarter and full year 2024 earnings conference call scheduled for March 6, 2025, at 5 p.m. ET TORONTO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. ("TerrAscend" or the "Company") (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabi...

 PRESS RELEASE

TerrAscend Appoints Lynn Gefen to Expanded Role of Chief People Office...

TerrAscend Appoints Lynn Gefen to Expanded Role of Chief People Officer TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced the appointment of Lynn Gefen as Chief People Officer in addition to her existing role as Chief Legal Officer and Corporate Secretary, effective November 12, 2024. “Lynn has proven to be an exceptional member of our leadership team since she joined TerrAscend in May of 2022. She has brought not only technical expertise, but a passion for ...

 PRESS RELEASE

TerrAscend Reports Third Quarter 2024 Financial Results

TerrAscend Reports Third Quarter 2024 Financial Results Net Revenue of $74.2 million and Gross Profit Margin of 48.8% 9th consecutive quarter of positive Cash Flow from continuing operations and fifth consecutive quarter of positive Free Cash Flow1 Closed on a senior secured term loan for gross proceeds of $140 million carrying an interest rate of 12.75%, maturing in August 2028, and containing no warrants or prepayment penalties Announced today the signing of definitive agreement to enter Ohio market through the acquisition of a well situated, profitable dispensary TORONTO, Nov. 06, 2...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch